Global Antifungal infection Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Antifungal infection Therapeutics market size was valued at US$ 18250 million in 2023. With growing demand in downstream market, the Antifungal infection Therapeutics is forecast to a readjusted size of US$ 29330 million by 2030 with a CAGR of 7.0% during review period.
The research report highlights the growth potential of the global Antifungal infection Therapeutics market. Antifungal infection Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antifungal infection Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antifungal infection Therapeutics market.
Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antifungal infection Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antifungal infection Therapeutics market. It may include historical data, market segmentation by Type (e.g., Polyenes, Echinocandins), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antifungal infection Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antifungal infection Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antifungal infection Therapeutics industry. This include advancements in Antifungal infection Therapeutics technology, Antifungal infection Therapeutics new entrants, Antifungal infection Therapeutics new investment, and other innovations that are shaping the future of Antifungal infection Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antifungal infection Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Antifungal infection Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antifungal infection Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antifungal infection Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antifungal infection Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antifungal infection Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antifungal infection Therapeutics market.
Market Segmentation:
Antifungal infection Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Antifungal infection Therapeutics market size was valued at US$ 18250 million in 2023. With growing demand in downstream market, the Antifungal infection Therapeutics is forecast to a readjusted size of US$ 29330 million by 2030 with a CAGR of 7.0% during review period.
The research report highlights the growth potential of the global Antifungal infection Therapeutics market. Antifungal infection Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Antifungal infection Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Antifungal infection Therapeutics market.
Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Antifungal infection Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Antifungal infection Therapeutics market. It may include historical data, market segmentation by Type (e.g., Polyenes, Echinocandins), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Antifungal infection Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Antifungal infection Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Antifungal infection Therapeutics industry. This include advancements in Antifungal infection Therapeutics technology, Antifungal infection Therapeutics new entrants, Antifungal infection Therapeutics new investment, and other innovations that are shaping the future of Antifungal infection Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Antifungal infection Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Antifungal infection Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Antifungal infection Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Antifungal infection Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Antifungal infection Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Antifungal infection Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Antifungal infection Therapeutics market.
Market Segmentation:
Antifungal infection Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Polyenes
- Echinocandins
- Azoles
- Allylamines
- Other Drug types
- Hospitals and Clinics
- Dermatology Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Scynexis
- Sanofi-Aventis
- Pfizer
- Novartis
- Merck & Co
- Kramer Laboratories
- Johnson & Johnson
- ID Sigma-Aldrich Corporation
- Glenmark Pharmaceuticals
- Glaxosmithkline
- Enzon Pharmaceuticals
- Bayer Healthcare
- Astellas Pharma
- Asperqillus
- Alternaria
- Abbott Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antifungal infection Therapeutics Market Size 2019-2030
2.1.2 Antifungal infection Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antifungal infection Therapeutics Segment by Type
2.2.1 Polyenes
2.2.2 Echinocandins
2.2.3 Azoles
2.2.4 Allylamines
2.2.5 Other Drug types
2.3 Antifungal infection Therapeutics Market Size by Type
2.3.1 Antifungal infection Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Antifungal infection Therapeutics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Dermatology Clinic
2.5 Antifungal infection Therapeutics Market Size by Application
2.5.1 Antifungal infection Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTIFUNGAL INFECTION THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Antifungal infection Therapeutics Market Size Market Share by Players
3.1.1 Global Antifungal infection Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antifungal infection Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIFUNGAL INFECTION THERAPEUTICS BY REGIONS
4.1 Antifungal infection Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.3 APAC Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.4 Europe Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Antifungal infection Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antifungal infection Therapeutics Market Size by Country (2019-2024)
5.2 Americas Antifungal infection Therapeutics Market Size by Type (2019-2024)
5.3 Americas Antifungal infection Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antifungal infection Therapeutics Market Size by Region (2019-2024)
6.2 APAC Antifungal infection Therapeutics Market Size by Type (2019-2024)
6.3 APAC Antifungal infection Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antifungal infection Therapeutics by Country (2019-2024)
7.2 Europe Antifungal infection Therapeutics Market Size by Type (2019-2024)
7.3 Europe Antifungal infection Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antifungal infection Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIFUNGAL INFECTION THERAPEUTICS MARKET FORECAST
10.1 Global Antifungal infection Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Antifungal infection Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Antifungal infection Therapeutics Forecast
10.1.3 APAC Antifungal infection Therapeutics Forecast
10.1.4 Europe Antifungal infection Therapeutics Forecast
10.1.5 Middle East & Africa Antifungal infection Therapeutics Forecast
10.2 Americas Antifungal infection Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Antifungal infection Therapeutics Market Forecast
10.2.2 Canada Antifungal infection Therapeutics Market Forecast
10.2.3 Mexico Antifungal infection Therapeutics Market Forecast
10.2.4 Brazil Antifungal infection Therapeutics Market Forecast
10.3 APAC Antifungal infection Therapeutics Forecast by Region (2025-2030)
10.3.1 China Antifungal infection Therapeutics Market Forecast
10.3.2 Japan Antifungal infection Therapeutics Market Forecast
10.3.3 Korea Antifungal infection Therapeutics Market Forecast
10.3.4 Southeast Asia Antifungal infection Therapeutics Market Forecast
10.3.5 India Antifungal infection Therapeutics Market Forecast
10.3.6 Australia Antifungal infection Therapeutics Market Forecast
10.4 Europe Antifungal infection Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Antifungal infection Therapeutics Market Forecast
10.4.2 France Antifungal infection Therapeutics Market Forecast
10.4.3 UK Antifungal infection Therapeutics Market Forecast
10.4.4 Italy Antifungal infection Therapeutics Market Forecast
10.4.5 Russia Antifungal infection Therapeutics Market Forecast
10.5 Middle East & Africa Antifungal infection Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Antifungal infection Therapeutics Market Forecast
10.5.2 South Africa Antifungal infection Therapeutics Market Forecast
10.5.3 Israel Antifungal infection Therapeutics Market Forecast
10.5.4 Turkey Antifungal infection Therapeutics Market Forecast
10.5.5 GCC Countries Antifungal infection Therapeutics Market Forecast
10.6 Global Antifungal infection Therapeutics Forecast by Type (2025-2030)
10.7 Global Antifungal infection Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Scynexis
11.1.1 Scynexis Company Information
11.1.2 Scynexis Antifungal infection Therapeutics Product Offered
11.1.3 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Scynexis Main Business Overview
11.1.5 Scynexis Latest Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Information
11.2.2 Sanofi-Aventis Antifungal infection Therapeutics Product Offered
11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi-Aventis Main Business Overview
11.2.5 Sanofi-Aventis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Antifungal infection Therapeutics Product Offered
11.3.3 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Antifungal infection Therapeutics Product Offered
11.4.3 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Merck & Co
11.5.1 Merck & Co Company Information
11.5.2 Merck & Co Antifungal infection Therapeutics Product Offered
11.5.3 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck & Co Main Business Overview
11.5.5 Merck & Co Latest Developments
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Information
11.6.2 Kramer Laboratories Antifungal infection Therapeutics Product Offered
11.6.3 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Kramer Laboratories Main Business Overview
11.6.5 Kramer Laboratories Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Antifungal infection Therapeutics Product Offered
11.7.3 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 ID Sigma-Aldrich Corporation
11.8.1 ID Sigma-Aldrich Corporation Company Information
11.8.2 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product Offered
11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ID Sigma-Aldrich Corporation Main Business Overview
11.8.5 ID Sigma-Aldrich Corporation Latest Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Information
11.9.2 Glenmark Pharmaceuticals Antifungal infection Therapeutics Product Offered
11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Pharmaceuticals Main Business Overview
11.9.5 Glenmark Pharmaceuticals Latest Developments
11.10 Glaxosmithkline
11.10.1 Glaxosmithkline Company Information
11.10.2 Glaxosmithkline Antifungal infection Therapeutics Product Offered
11.10.3 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Glaxosmithkline Main Business Overview
11.10.5 Glaxosmithkline Latest Developments
11.11 Enzon Pharmaceuticals
11.11.1 Enzon Pharmaceuticals Company Information
11.11.2 Enzon Pharmaceuticals Antifungal infection Therapeutics Product Offered
11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Enzon Pharmaceuticals Main Business Overview
11.11.5 Enzon Pharmaceuticals Latest Developments
11.12 Bayer Healthcare
11.12.1 Bayer Healthcare Company Information
11.12.2 Bayer Healthcare Antifungal infection Therapeutics Product Offered
11.12.3 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bayer Healthcare Main Business Overview
11.12.5 Bayer Healthcare Latest Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Information
11.13.2 Astellas Pharma Antifungal infection Therapeutics Product Offered
11.13.3 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Astellas Pharma Main Business Overview
11.13.5 Astellas Pharma Latest Developments
11.14 Asperqillus
11.14.1 Asperqillus Company Information
11.14.2 Asperqillus Antifungal infection Therapeutics Product Offered
11.14.3 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Asperqillus Main Business Overview
11.14.5 Asperqillus Latest Developments
11.15 Alternaria
11.15.1 Alternaria Company Information
11.15.2 Alternaria Antifungal infection Therapeutics Product Offered
11.15.3 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Alternaria Main Business Overview
11.15.5 Alternaria Latest Developments
11.16 Abbott Laboratories
11.16.1 Abbott Laboratories Company Information
11.16.2 Abbott Laboratories Antifungal infection Therapeutics Product Offered
11.16.3 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Abbott Laboratories Main Business Overview
11.16.5 Abbott Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antifungal infection Therapeutics Market Size 2019-2030
2.1.2 Antifungal infection Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antifungal infection Therapeutics Segment by Type
2.2.1 Polyenes
2.2.2 Echinocandins
2.2.3 Azoles
2.2.4 Allylamines
2.2.5 Other Drug types
2.3 Antifungal infection Therapeutics Market Size by Type
2.3.1 Antifungal infection Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Antifungal infection Therapeutics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Dermatology Clinic
2.5 Antifungal infection Therapeutics Market Size by Application
2.5.1 Antifungal infection Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
3 ANTIFUNGAL INFECTION THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Antifungal infection Therapeutics Market Size Market Share by Players
3.1.1 Global Antifungal infection Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antifungal infection Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIFUNGAL INFECTION THERAPEUTICS BY REGIONS
4.1 Antifungal infection Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.3 APAC Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.4 Europe Antifungal infection Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Antifungal infection Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Antifungal infection Therapeutics Market Size by Country (2019-2024)
5.2 Americas Antifungal infection Therapeutics Market Size by Type (2019-2024)
5.3 Americas Antifungal infection Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antifungal infection Therapeutics Market Size by Region (2019-2024)
6.2 APAC Antifungal infection Therapeutics Market Size by Type (2019-2024)
6.3 APAC Antifungal infection Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antifungal infection Therapeutics by Country (2019-2024)
7.2 Europe Antifungal infection Therapeutics Market Size by Type (2019-2024)
7.3 Europe Antifungal infection Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antifungal infection Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIFUNGAL INFECTION THERAPEUTICS MARKET FORECAST
10.1 Global Antifungal infection Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Antifungal infection Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Antifungal infection Therapeutics Forecast
10.1.3 APAC Antifungal infection Therapeutics Forecast
10.1.4 Europe Antifungal infection Therapeutics Forecast
10.1.5 Middle East & Africa Antifungal infection Therapeutics Forecast
10.2 Americas Antifungal infection Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Antifungal infection Therapeutics Market Forecast
10.2.2 Canada Antifungal infection Therapeutics Market Forecast
10.2.3 Mexico Antifungal infection Therapeutics Market Forecast
10.2.4 Brazil Antifungal infection Therapeutics Market Forecast
10.3 APAC Antifungal infection Therapeutics Forecast by Region (2025-2030)
10.3.1 China Antifungal infection Therapeutics Market Forecast
10.3.2 Japan Antifungal infection Therapeutics Market Forecast
10.3.3 Korea Antifungal infection Therapeutics Market Forecast
10.3.4 Southeast Asia Antifungal infection Therapeutics Market Forecast
10.3.5 India Antifungal infection Therapeutics Market Forecast
10.3.6 Australia Antifungal infection Therapeutics Market Forecast
10.4 Europe Antifungal infection Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Antifungal infection Therapeutics Market Forecast
10.4.2 France Antifungal infection Therapeutics Market Forecast
10.4.3 UK Antifungal infection Therapeutics Market Forecast
10.4.4 Italy Antifungal infection Therapeutics Market Forecast
10.4.5 Russia Antifungal infection Therapeutics Market Forecast
10.5 Middle East & Africa Antifungal infection Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Antifungal infection Therapeutics Market Forecast
10.5.2 South Africa Antifungal infection Therapeutics Market Forecast
10.5.3 Israel Antifungal infection Therapeutics Market Forecast
10.5.4 Turkey Antifungal infection Therapeutics Market Forecast
10.5.5 GCC Countries Antifungal infection Therapeutics Market Forecast
10.6 Global Antifungal infection Therapeutics Forecast by Type (2025-2030)
10.7 Global Antifungal infection Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Scynexis
11.1.1 Scynexis Company Information
11.1.2 Scynexis Antifungal infection Therapeutics Product Offered
11.1.3 Scynexis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Scynexis Main Business Overview
11.1.5 Scynexis Latest Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Information
11.2.2 Sanofi-Aventis Antifungal infection Therapeutics Product Offered
11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi-Aventis Main Business Overview
11.2.5 Sanofi-Aventis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Antifungal infection Therapeutics Product Offered
11.3.3 Pfizer Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Antifungal infection Therapeutics Product Offered
11.4.3 Novartis Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Merck & Co
11.5.1 Merck & Co Company Information
11.5.2 Merck & Co Antifungal infection Therapeutics Product Offered
11.5.3 Merck & Co Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck & Co Main Business Overview
11.5.5 Merck & Co Latest Developments
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Information
11.6.2 Kramer Laboratories Antifungal infection Therapeutics Product Offered
11.6.3 Kramer Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Kramer Laboratories Main Business Overview
11.6.5 Kramer Laboratories Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Antifungal infection Therapeutics Product Offered
11.7.3 Johnson & Johnson Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 ID Sigma-Aldrich Corporation
11.8.1 ID Sigma-Aldrich Corporation Company Information
11.8.2 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product Offered
11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ID Sigma-Aldrich Corporation Main Business Overview
11.8.5 ID Sigma-Aldrich Corporation Latest Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Information
11.9.2 Glenmark Pharmaceuticals Antifungal infection Therapeutics Product Offered
11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Pharmaceuticals Main Business Overview
11.9.5 Glenmark Pharmaceuticals Latest Developments
11.10 Glaxosmithkline
11.10.1 Glaxosmithkline Company Information
11.10.2 Glaxosmithkline Antifungal infection Therapeutics Product Offered
11.10.3 Glaxosmithkline Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Glaxosmithkline Main Business Overview
11.10.5 Glaxosmithkline Latest Developments
11.11 Enzon Pharmaceuticals
11.11.1 Enzon Pharmaceuticals Company Information
11.11.2 Enzon Pharmaceuticals Antifungal infection Therapeutics Product Offered
11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Enzon Pharmaceuticals Main Business Overview
11.11.5 Enzon Pharmaceuticals Latest Developments
11.12 Bayer Healthcare
11.12.1 Bayer Healthcare Company Information
11.12.2 Bayer Healthcare Antifungal infection Therapeutics Product Offered
11.12.3 Bayer Healthcare Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Bayer Healthcare Main Business Overview
11.12.5 Bayer Healthcare Latest Developments
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Information
11.13.2 Astellas Pharma Antifungal infection Therapeutics Product Offered
11.13.3 Astellas Pharma Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Astellas Pharma Main Business Overview
11.13.5 Astellas Pharma Latest Developments
11.14 Asperqillus
11.14.1 Asperqillus Company Information
11.14.2 Asperqillus Antifungal infection Therapeutics Product Offered
11.14.3 Asperqillus Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Asperqillus Main Business Overview
11.14.5 Asperqillus Latest Developments
11.15 Alternaria
11.15.1 Alternaria Company Information
11.15.2 Alternaria Antifungal infection Therapeutics Product Offered
11.15.3 Alternaria Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Alternaria Main Business Overview
11.15.5 Alternaria Latest Developments
11.16 Abbott Laboratories
11.16.1 Abbott Laboratories Company Information
11.16.2 Abbott Laboratories Antifungal infection Therapeutics Product Offered
11.16.3 Abbott Laboratories Antifungal infection Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Abbott Laboratories Main Business Overview
11.16.5 Abbott Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antifungal infection Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polyenes
Table 3. Major Players of Echinocandins
Table 4. Major Players of Azoles
Table 5. Major Players of Allylamines
Table 6. Major Players of Other Drug types
Table 7. Antifungal infection Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 10. Antifungal infection Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 13. Global Antifungal infection Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Antifungal infection Therapeutics Revenue Market Share by Player (2019-2024)
Table 15. Antifungal infection Therapeutics Key Players Head office and Products Offered
Table 16. Antifungal infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Antifungal infection Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Antifungal infection Therapeutics Market Size Market Share by Regions (2019-2024)
Table 21. Global Antifungal infection Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Antifungal infection Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Antifungal infection Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Antifungal infection Therapeutics Market Size Market Share by Country (2019-2024)
Table 25. Americas Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 27. Americas Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 29. APAC Antifungal infection Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Table 31. APAC Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 33. APAC Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 35. Europe Antifungal infection Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Antifungal infection Therapeutics Market Size Market Share by Country (2019-2024)
Table 37. Europe Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 39. Europe Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Antifungal infection Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Antifungal infection Therapeutics
Table 48. Key Market Challenges & Risks of Antifungal infection Therapeutics
Table 49. Key Industry Trends of Antifungal infection Therapeutics
Table 50. Global Antifungal infection Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Antifungal infection Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Antifungal infection Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Scynexis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 55. Scynexis Antifungal infection Therapeutics Product Offered
Table 56. Scynexis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Scynexis Main Business
Table 58. Scynexis Latest Developments
Table 59. Sanofi-Aventis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 60. Sanofi-Aventis Antifungal infection Therapeutics Product Offered
Table 61. Sanofi-Aventis Main Business
Table 62. Sanofi-Aventis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sanofi-Aventis Latest Developments
Table 64. Pfizer Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 65. Pfizer Antifungal infection Therapeutics Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Pfizer Latest Developments
Table 69. Novartis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 70. Novartis Antifungal infection Therapeutics Product Offered
Table 71. Novartis Main Business
Table 72. Novartis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Novartis Latest Developments
Table 74. Merck & Co Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 75. Merck & Co Antifungal infection Therapeutics Product Offered
Table 76. Merck & Co Main Business
Table 77. Merck & Co Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Merck & Co Latest Developments
Table 79. Kramer Laboratories Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 80. Kramer Laboratories Antifungal infection Therapeutics Product Offered
Table 81. Kramer Laboratories Main Business
Table 82. Kramer Laboratories Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Kramer Laboratories Latest Developments
Table 84. Johnson & Johnson Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 85. Johnson & Johnson Antifungal infection Therapeutics Product Offered
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Johnson & Johnson Latest Developments
Table 89. ID Sigma-Aldrich Corporation Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 90. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product Offered
Table 91. ID Sigma-Aldrich Corporation Main Business
Table 92. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. ID Sigma-Aldrich Corporation Latest Developments
Table 94. Glenmark Pharmaceuticals Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 95. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product Offered
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Glenmark Pharmaceuticals Latest Developments
Table 99. Glaxosmithkline Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 100. Glaxosmithkline Antifungal infection Therapeutics Product Offered
Table 101. Glaxosmithkline Main Business
Table 102. Glaxosmithkline Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Glaxosmithkline Latest Developments
Table 104. Enzon Pharmaceuticals Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 105. Enzon Pharmaceuticals Antifungal infection Therapeutics Product Offered
Table 106. Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Enzon Pharmaceuticals Main Business
Table 108. Enzon Pharmaceuticals Latest Developments
Table 109. Bayer Healthcare Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 110. Bayer Healthcare Antifungal infection Therapeutics Product Offered
Table 111. Bayer Healthcare Main Business
Table 112. Bayer Healthcare Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Bayer Healthcare Latest Developments
Table 114. Astellas Pharma Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 115. Astellas Pharma Antifungal infection Therapeutics Product Offered
Table 116. Astellas Pharma Main Business
Table 117. Astellas Pharma Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Astellas Pharma Latest Developments
Table 119. Asperqillus Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 120. Asperqillus Antifungal infection Therapeutics Product Offered
Table 121. Asperqillus Main Business
Table 122. Asperqillus Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Asperqillus Latest Developments
Table 124. Alternaria Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 125. Alternaria Antifungal infection Therapeutics Product Offered
Table 126. Alternaria Main Business
Table 127. Alternaria Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Alternaria Latest Developments
Table 129. Abbott Laboratories Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 130. Abbott Laboratories Antifungal infection Therapeutics Product Offered
Table 131. Abbott Laboratories Main Business
Table 132. Abbott Laboratories Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Abbott Laboratories Latest Developments
Table 1. Antifungal infection Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polyenes
Table 3. Major Players of Echinocandins
Table 4. Major Players of Azoles
Table 5. Major Players of Allylamines
Table 6. Major Players of Other Drug types
Table 7. Antifungal infection Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 10. Antifungal infection Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 13. Global Antifungal infection Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Antifungal infection Therapeutics Revenue Market Share by Player (2019-2024)
Table 15. Antifungal infection Therapeutics Key Players Head office and Products Offered
Table 16. Antifungal infection Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Antifungal infection Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Antifungal infection Therapeutics Market Size Market Share by Regions (2019-2024)
Table 21. Global Antifungal infection Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Antifungal infection Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Antifungal infection Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Antifungal infection Therapeutics Market Size Market Share by Country (2019-2024)
Table 25. Americas Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 27. Americas Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 29. APAC Antifungal infection Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Table 31. APAC Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 33. APAC Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 35. Europe Antifungal infection Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Antifungal infection Therapeutics Market Size Market Share by Country (2019-2024)
Table 37. Europe Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 39. Europe Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Antifungal infection Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Antifungal infection Therapeutics
Table 48. Key Market Challenges & Risks of Antifungal infection Therapeutics
Table 49. Key Industry Trends of Antifungal infection Therapeutics
Table 50. Global Antifungal infection Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Antifungal infection Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Antifungal infection Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Scynexis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 55. Scynexis Antifungal infection Therapeutics Product Offered
Table 56. Scynexis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Scynexis Main Business
Table 58. Scynexis Latest Developments
Table 59. Sanofi-Aventis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 60. Sanofi-Aventis Antifungal infection Therapeutics Product Offered
Table 61. Sanofi-Aventis Main Business
Table 62. Sanofi-Aventis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sanofi-Aventis Latest Developments
Table 64. Pfizer Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 65. Pfizer Antifungal infection Therapeutics Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Pfizer Latest Developments
Table 69. Novartis Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 70. Novartis Antifungal infection Therapeutics Product Offered
Table 71. Novartis Main Business
Table 72. Novartis Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Novartis Latest Developments
Table 74. Merck & Co Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 75. Merck & Co Antifungal infection Therapeutics Product Offered
Table 76. Merck & Co Main Business
Table 77. Merck & Co Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Merck & Co Latest Developments
Table 79. Kramer Laboratories Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 80. Kramer Laboratories Antifungal infection Therapeutics Product Offered
Table 81. Kramer Laboratories Main Business
Table 82. Kramer Laboratories Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Kramer Laboratories Latest Developments
Table 84. Johnson & Johnson Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 85. Johnson & Johnson Antifungal infection Therapeutics Product Offered
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Johnson & Johnson Latest Developments
Table 89. ID Sigma-Aldrich Corporation Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 90. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Product Offered
Table 91. ID Sigma-Aldrich Corporation Main Business
Table 92. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. ID Sigma-Aldrich Corporation Latest Developments
Table 94. Glenmark Pharmaceuticals Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 95. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product Offered
Table 96. Glenmark Pharmaceuticals Main Business
Table 97. Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Glenmark Pharmaceuticals Latest Developments
Table 99. Glaxosmithkline Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 100. Glaxosmithkline Antifungal infection Therapeutics Product Offered
Table 101. Glaxosmithkline Main Business
Table 102. Glaxosmithkline Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Glaxosmithkline Latest Developments
Table 104. Enzon Pharmaceuticals Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 105. Enzon Pharmaceuticals Antifungal infection Therapeutics Product Offered
Table 106. Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Enzon Pharmaceuticals Main Business
Table 108. Enzon Pharmaceuticals Latest Developments
Table 109. Bayer Healthcare Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 110. Bayer Healthcare Antifungal infection Therapeutics Product Offered
Table 111. Bayer Healthcare Main Business
Table 112. Bayer Healthcare Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Bayer Healthcare Latest Developments
Table 114. Astellas Pharma Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 115. Astellas Pharma Antifungal infection Therapeutics Product Offered
Table 116. Astellas Pharma Main Business
Table 117. Astellas Pharma Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Astellas Pharma Latest Developments
Table 119. Asperqillus Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 120. Asperqillus Antifungal infection Therapeutics Product Offered
Table 121. Asperqillus Main Business
Table 122. Asperqillus Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Asperqillus Latest Developments
Table 124. Alternaria Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 125. Alternaria Antifungal infection Therapeutics Product Offered
Table 126. Alternaria Main Business
Table 127. Alternaria Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Alternaria Latest Developments
Table 129. Abbott Laboratories Details, Company Type, Antifungal infection Therapeutics Area Served and Its Competitors
Table 130. Abbott Laboratories Antifungal infection Therapeutics Product Offered
Table 131. Abbott Laboratories Main Business
Table 132. Abbott Laboratories Antifungal infection Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Abbott Laboratories Latest Developments
LIST OF FIGURES
Figure 1. Antifungal infection Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antifungal infection Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Antifungal infection Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antifungal infection Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Antifungal infection Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antifungal infection Therapeutics Market Size Market Share by Type in 2023
Figure 10. Antifungal infection Therapeutics in Hospitals and Clinics
Figure 11. Global Antifungal infection Therapeutics Market: Hospitals and Clinics (2019-2024) & ($ Millions)
Figure 12. Antifungal infection Therapeutics in Dermatology Clinic
Figure 13. Global Antifungal infection Therapeutics Market: Dermatology Clinic (2019-2024) & ($ Millions)
Figure 14. Global Antifungal infection Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Antifungal infection Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Antifungal infection Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Antifungal infection Therapeutics Value Market Share by Country in 2023
Figure 22. United States Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Antifungal infection Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Antifungal infection Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Antifungal infection Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Antifungal infection Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Antifungal infection Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antifungal infection Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Antifungal infection Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antifungal infection Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Antifungal infection Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antifungal infection Therapeutics Market Size Market Share by Type in 2023
Figure 10. Antifungal infection Therapeutics in Hospitals and Clinics
Figure 11. Global Antifungal infection Therapeutics Market: Hospitals and Clinics (2019-2024) & ($ Millions)
Figure 12. Antifungal infection Therapeutics in Dermatology Clinic
Figure 13. Global Antifungal infection Therapeutics Market: Dermatology Clinic (2019-2024) & ($ Millions)
Figure 14. Global Antifungal infection Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Antifungal infection Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Antifungal infection Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Antifungal infection Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Antifungal infection Therapeutics Value Market Share by Country in 2023
Figure 22. United States Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Antifungal infection Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Antifungal infection Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Antifungal infection Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Antifungal infection Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Antifungal infection Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Antifungal infection Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Antifungal infection Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Antifungal infection Therapeutics Market Size Market Share Forecast by Application (2025-2030)
